Kazuaki Taguchi Selected Research

Invasive Candidiasis

11/2021	Population Pharmacokinetic Analysis and Dosing Optimization of Prophylactic Fluconazole in Japanese Patients with Hematological Malignancy.
11/2020	Echinocandins versus non-echinocandins for the treatment of invasive candidiasis: A meta-analysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuaki Taguchi Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 01/2018
10	Hemorrhage 01/2021 - 04/2011
9	Hemorrhagic Shock 11/2020 - 06/2009
6	Infections 03/2022 - 01/2020
5	Chronic Renal Insufficiency 01/2022 - 12/2012
5	Fibrosis (Cirrhosis) 01/2022 - 02/2011
5	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2013
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2019
4	Wounds and Injuries (Trauma) 01/2020 - 02/2015
4	Inflammation (Inflammations) 01/2016 - 09/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2018
3	Hypoxia (Hypoxemia) 01/2022 - 10/2015
3	Poisoning 01/2022 - 10/2021
3	Hypoalbuminemia 06/2021 - 12/2010
3	Renal Insufficiency (Renal Failure) 01/2013 - 07/2007
2	Meningitis 08/2022 - 09/2021
2	Bacterial Meningitis 08/2022 - 09/2021
2	Rhabdomyolysis 01/2022 - 01/2020
2	Invasive Candidiasis 11/2021 - 11/2020
2	Clostridium Infections 10/2021 - 11/2018
2	Candidemia 07/2021 - 11/2020
2	Chronic Hepatitis B 01/2020 - 06/2018
2	Pain (Aches) 05/2019 - 12/2012
2	Hepatitis 11/2018 - 02/2015
2	Pancreatitis 11/2018 - 01/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2018 - 01/2015
2	Hypertension (High Blood Pressure) 01/2018 - 12/2009
2	Lung Injury 01/2016 - 09/2011
2	Fetal Hypoxia 10/2015 - 10/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2012 - 07/2007
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2011 - 11/2010
1	Bacteremia 03/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Pneumonia (Pneumonitis) 01/2022

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 12/2021 - 10/2013
12	Carbon MonoxideIBA 01/2022 - 01/2013
12	Hemoglobins (Hemoglobin)IBA 12/2021 - 06/2009
8	Liposomes (Liposome)IBA 12/2021 - 03/2011
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 09/2011
7	AlbuminsIBA 01/2020 - 12/2010
6	Oxygen (Dioxygen)IBA 01/2020 - 06/2009
6	Human Serum Albumin FDA LinkGeneric 11/2019 - 12/2010
5	Therapeutic UsesIBA 01/2022 - 08/2014
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2020 - 01/2013
5	AntioxidantsIBA 01/2018 - 01/2015
4	Vancomycin FDA LinkGeneric 03/2022 - 11/2018
4	Daptomycin FDA Link 03/2022 - 01/2020
4	EchinocandinsIBA 01/2022 - 11/2020
4	CytokinesIBA 01/2016 - 08/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2020
3	AntidotesIBA 01/2022 - 10/2021
3	MethemoglobinIBA 01/2022 - 10/2021
3	Cyanides (Isocyanides)IBA 01/2022 - 10/2021
3	Linezolid (Zyvox)FDA Link 01/2022 - 01/2013
3	NucleosidesIBA 05/2021 - 06/2018
3	4'-cyano-2'-deoxyguanosineIBA 05/2021 - 06/2018
3	Fibrinogen (Factor I)FDA Link 09/2015 - 08/2013
3	Immunoglobulin M (IgM)IBA 09/2015 - 03/2011
3	Adenosine Diphosphate (ADP)IBA 09/2015 - 08/2013
3	Biological ProductsIBA 08/2015 - 01/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015 - 07/2007
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2022 - 12/2019
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2022 - 10/2021
2	SuspensionsIBA 12/2021 - 01/2016
2	beta-Lactamases (beta-Lactamase)IBA 11/2021 - 01/2021
2	A-factor (Streptomyces)IBA 10/2021 - 12/2019
2	Metronidazole (Metric)FDA LinkGeneric 10/2021 - 11/2018
2	PolyenesIBA 11/2020 - 11/2020
2	CytochromesIBA 10/2020 - 01/2013
2	Antiviral Agents (Antivirals)IBA 01/2020 - 06/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 11/2019
2	SaltsIBA 12/2019 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 05/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2018
2	BenzbromaroneIBA 01/2018 - 01/2015
2	Heme (Haem)IBA 10/2015 - 07/2014
2	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2015 - 12/2012
2	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2011 - 11/2010
1	Ceftazidime (Fortum)FDA LinkGeneric 08/2022
1	Adenosine Monophosphate (AMP)IBA 03/2022
1	tedizolidIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2022
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	NivolumabIBA 01/2022
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	CytidineIBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022

Therapy/Procedure

9	Resuscitation 11/2020 - 06/2009
8	Therapeutics 01/2022 - 10/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2020
2	Oral Administration 05/2019 - 01/2018
2	Erythrocyte Transfusion 11/2015 - 01/2013
2	Injections 09/2015 - 03/2011
2	Ligation 10/2012 - 04/2011
1	Lung Transplantation 01/2022